Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Research
    • Structural Heart Disease
    • TAVR
    • Therapies
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe

Search form

Home
News You Need to Know Today
News Alert: FDA announces another recall of common hypertension medication due to potential cancer risk
Monday, April 25, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

News Alert

FDA announces another recall of common hypertension medication due to potential cancer risk

The new recall includes five lots of medications distributed from December 2019 to April 2022. Similar products were also recalled back in March for the same reason.

READ MORE >
The new recall includes five lots of medications distributed from December 2019 to April 2022. Similar products were also recalled back in March for the same reason. The FDA recalled Accupril from Pfizer.
Share on Twitter Share on Facebook Share on Linkedin

FDA announces another recall of common hypertension medication due to potential cancer risk

Share on Twitter Share on Facebook Share on Linkedin
The new recall includes five lots of medications distributed from December 2019 to April 2022. Similar products were also recalled back in March for the same reason. The FDA recalled Accupril from Pfizer.
The new recall includes five lots of medications distributed from December 2019 to April 2022. Similar products were also recalled back in March for the same reason.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

December's Top Stories: Deaths lead to major recalls | IVL a top priority | Mass layoffs | Heart surgeon discusses robotic AVR
Our favorite Q&A interviews of the year: Device recalls | Robotic AVR | Tricuspid breakthroughs | Much more!
Patient deaths lead to device recalls | Cardiologists perform first-in-human heart procedures | AFib & TAVR
CMS proposes Medicare coverage for TTVR | Hydra TAVR valve gains key approval | Palliative care for stroke survivors
IVL a top priority | Patient deaths lead to major recalls | First-in-human implants | FDA clears heart monitor | Doctor attacked
Drug shortage ends after 2 years | Exploring CCTA's value | Cardiologist attacked | The future of AI & vascular surgery
Cryoablation catheters recalled | Merck spends big on new drug | SAVR bests TAVR | FDA expands total artificial heart study

Pagination

    • First page « First
    • Previous page ‹ Previous
    • Page 1
    • Current page 2
    • Page 3
    • Page 4
    • Page 5
    • Page 6
    • Page 7
    • Page 8
    • Page 9 …
    • Next page Next ›
    • Last page Last »
  • Home
  • News
  • Sitemap
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • AI in Healthcare
  • Cardiovascular Business
  • HealthExec
  • Health Imaging
  • Radiology Business
 
© 2024 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme